Meet Akoya Biosciences and Quanterix at SITC 2025
Booth 804 | November 5–9, 2025 | National Harbor, MD, USA
Join us at the Society for Immunotherapy of Cancer (SITC) annual meeting to explore how spatial biology is advancing immuno-oncology. Whether you're focused on translational research or discovering clinical biomarkers, Akoya Biosciences’ spatial solutions are designed to help you unlock deeper insights from tissue.
📍 Gaylord National Resort & Convention Center National Harbor
201 Waterfront St, Oxon Hill, MD 20745, United States
📅 Meet with us
Want to ensure that you connect with a spatial biology expert during SITC? Use the form on this page to request a meeting with our team.
Connect with us at booth 804
We would love to see you in person at the conference and hear about your research. Akoya Bioscience scientists, product experts, and marketing leaders are all attending SITC. Learn how our platforms—including the PhenoCycler®-Fusion and PhenoImager® HT—are helping researchers accelerate biomarker discovery and therapeutic development.
Visit our poster presentations
Both of our posters are presented on Friday, November 7, from 12:15–1:45 p.m. ET in the Lower Level Atrium.
Presented by
Yuting Liu, PhD
Associate Director, ABS Clinical Biomarker, Akoya Biosciences
Presented by
Katherine Hales, PhD
Director of Research Solutions and Channel Partnerships, Visiopharm
SITC posters featuring our platforms
Friday, November 7, 2025, from 12:15–1:45 p.m. ET
| Poster | Title |
|---|---|
| 1105 | The Enable Pancancer Atlas: Utilizing a Multi-cohort Spatial Proteomics Database for In Silico Clinical Patient Stratification of Checkpoint Blockade Immunotherapy in Hepatocellular Carcinoma |
| 1129 | Embedding-guided Patch Selection Improves Early Model Confidence in Multiplex Tissue Imaging |
| 1165 | IMNN-001, IL-12 Gene Therapy, Added to Neo/adjuvant Chemotherapy Safely Turns the Tumor Microenvironment Cold-to-hot in Newly Diagnosed Epithelial Ovarian Cancer (EOC) |
| 1223 | Unraveling Glioblastoma Spatial Signatures Using an Ultrahigh-plex Discovery to High-throughput Translational Spatial Platform Approach |
| 1285 | Spatial Organization of MYC+BCL2+BCL6- Cells Predicts Survival and Defines Immunosuppressive Microenvironments in Diffuse Large B-cell Lymphoma |
Saturday, November 8, 2025, from 12:15–1:45 p.m. ET
| Poster | Title |
|---|---|
| 474 | Disabling PSGL-1 Abrogates Immune Suppression and Resistance to PD-1 Blockade in Pancreatic Cancer |
| 478 | Spatial Omics and Deep Learning Define an Immunotherapy Resistance Niche in Hepatocellular Carcinoma |
| 654 | Oncolytic Viral Therapy Macrophage Reprogramming is Critical for Establishing the Immune Infiltrate Which Supported by IL-15 Reverses Immune Checkpoint Inhibitor Unresponsiveness of Prostate Cancer |
| 806 | Unraveling the Spatial Distribution and Interactions of NK Cell Subsets in the Tumor Microenvironment of Non-small Cell Lung Cancer Using Spatial Transcriptomics |
| 970 | Optimal Evaluation of NK Cell Immunotherapy in Novel Humanized Mouse Models of Cancer |
| 1230 | Enhancing Tissue Microarray Design for Immune Profiling: Tissue Microarray vs Whole-slide Quantification of CD8 in Non-small Cell Lung Carcinoma |